Topics:
Melanoma/Skin Cancer • Medical Oncology
How do you approach patients with stage III melanoma for adjuvant treatment?
Which group of patients will benefit with observation versus adjuvant immunotherapy?
Answer from: Medical Oncologist at Academic Institution
Currently, there are FDA-approved adjuvant systemic therapy for stage III melanoma. These were based on the CheckMate 238 study (adjuvant nivolumab), KEYNOTE-054 (adjuvant pembrolizumab), and COMBI-AD study (adjuvant dabrafenib/trametinib). The KEYNOTE-054 compared adjuvant pembro vs placebo, with H...
Sign in or Register to read more